Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.

Turato C, Vitale A, Fasolato S, Ruvoletto M, Terrin L, Quarta S, Ramirez Morales R, Biasiolo A, Zanus G, Zali N, Tan PS, Hoshida Y, Gatta A, Cillo U, Pontisso P.

Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8.

2.

SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.

Terrin L, Agostini M, Ruvoletto M, Martini A, Pucciarelli S, Bedin C, Nitti D, Pontisso P.

Oncotarget. 2017 Feb 28;8(9):15732-15743. doi: 10.18632/oncotarget.14997.

3.

SERPINB3 modulates TGF-beta expression in chronic liver disease.

Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Merkel C, Harrison TJ, Gatta A, Pontisso P.

Lab Invest. 2010 Jul;90(7):1016-23. doi: 10.1038/labinvest.2010.55. Epub 2010 Mar 8.

4.

The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.

Ji F, Fu SJ, Shen SL, Zhang LJ, Cao QH, Li SQ, Peng BG, Liang LJ, Hua YP.

BMC Cancer. 2015 Mar 11;15:116. doi: 10.1186/s12885-015-1127-y.

5.

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

Cannito S, Turato C, Paternostro C, Biasiolo A, Colombatto S, Cambieri I, Quarta S, Novo E, Morello E, Villano G, Fasolato S, Musso T, David E, Tusa I, Rovida E, Autelli R, Smedile A, Cillo U, Pontisso P, Parola M.

Oncotarget. 2015 Feb 10;6(4):2206-21.

6.

SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.

Fasolato S, Trevellin E, Ruvoletto M, Granzotto M, Zanus G, Boscaro E, Babetto E, Terrin L, Battocchio MA, Ciscato F, Turato C, Quarta S, Cillo U, Pontisso P, Vettor R.

Life Sci. 2018 May 1;200:134-141. doi: 10.1016/j.lfs.2018.03.014. Epub 2018 Mar 7.

PMID:
29524519
7.

Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.

Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC, Hsu HC.

J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.

PMID:
21061181
8.

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.

von Felden J, Heim D, Schulze K, Krech T, Ewald F, Nashan B, Lohse AW, Wege H.

BMC Cancer. 2017 Jan 18;17(1):60. doi: 10.1186/s12885-017-3053-7.

9.

Role of SERPINB3 in hepatocellular carcinoma.

Pontisso P.

Ann Hepatol. 2014 Nov-Dec;13(6):722-7. Review.

10.

Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.

Chen J, Liu J, Jin R, Shen J, Liang Y, Ma R, Lin H, Liang X, Yu H, Cai X.

PLoS One. 2014 Nov 17;9(11):e111885. doi: 10.1371/journal.pone.0111885. eCollection 2014.

11.

Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.

Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W.

J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9.

PMID:
19303159
12.

MicroRNAs and SerpinB3 in hepatocellular carcinoma.

Turato C, Simonato D, Quarta S, Gatta A, Pontisso P.

Life Sci. 2014 Mar 28;100(1):9-17. doi: 10.1016/j.lfs.2014.01.073. Epub 2014 Feb 2. Review.

PMID:
24496037
13.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
14.

Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.

Ruan H, Wang T, Yang C, Jin G, Gu D, Deng X, Wang C, Qin W, Jin H.

Sci Rep. 2016 Sep 1;6:32421. doi: 10.1038/srep32421.

16.

Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma.

Cha HJ, Kim J, Hong SM, Hong SJ, Park JH, Kim ES, Wang HJ, Choi YJ, Do IG, Joh JW, Kim DS, Choi KY.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S404-11. doi: 10.1245/s10434-011-1856-3. Epub 2011 Jun 30. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S321.

PMID:
21717246
17.

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.

Turato C, Cannito S, Simonato D, Villano G, Morello E, Terrin L, Quarta S, Biasiolo A, Ruvoletto M, Martini A, Fasolato S, Zanus G, Cillo U, Gatta A, Parola M, Pontisso P.

Sci Rep. 2015 Dec 4;5:17701. doi: 10.1038/srep17701.

18.

Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.

Zhang D, Ma X, Sun W, Cui P, Lu Z.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3386-94. eCollection 2015.

19.

Hepatic progenitor cells express SerpinB3.

Villano G, Turato C, Quarta S, Ruvoletto M, Ciscato F, Terrin L, Semeraro R, Paternostro C, Parola M, Alvaro D, Bernardi P, Gatta A, Pontisso P.

BMC Cell Biol. 2014 Feb 11;15:5. doi: 10.1186/1471-2121-15-5.

Supplemental Content

Support Center